To compare long term safety and efficacy of bioresorbable polymer biolimus A9 eluting stents with Everolimus and Zotarolimus eluting stents in patients with acute coronary syndrome

Trial Profile

To compare long term safety and efficacy of bioresorbable polymer biolimus A9 eluting stents with Everolimus and Zotarolimus eluting stents in patients with acute coronary syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Umirolimus (Primary) ; Everolimus; Zotarolimus
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top